[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

AR124267A1 - Métodos de alto rendimiento para preparar nanopartículas lipídicas y sus usos - Google Patents

Métodos de alto rendimiento para preparar nanopartículas lipídicas y sus usos

Info

Publication number
AR124267A1
AR124267A1 ARP210103407A ARP210103407A AR124267A1 AR 124267 A1 AR124267 A1 AR 124267A1 AR P210103407 A ARP210103407 A AR P210103407A AR P210103407 A ARP210103407 A AR P210103407A AR 124267 A1 AR124267 A1 AR 124267A1
Authority
AR
Argentina
Prior art keywords
lnp
self
mixing
payload
solutions
Prior art date
Application number
ARP210103407A
Other languages
English (en)
Inventor
Yuchen Fan
Chun Yen
- Zhang Ke Wan
Original Assignee
Genentech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genentech Inc filed Critical Genentech Inc
Publication of AR124267A1 publication Critical patent/AR124267A1/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51Nanocapsules; Nanoparticles
    • A61K9/5192Processes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/127Liposomes
    • A61K9/1277Processes for preparing; Proliposomes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/127Liposomes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7088Compounds having three or more nucleosides or nucleotides
    • A61K31/7105Natural ribonucleic acids, i.e. containing only riboses attached to adenine, guanine, cytosine or uracil and having 3'-5' phosphodiester links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7088Compounds having three or more nucleosides or nucleotides
    • A61K31/713Double-stranded nucleic acids or oligonucleotides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/127Liposomes
    • A61K9/1271Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers
    • A61K9/1272Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers with substantial amounts of non-phosphatidyl, i.e. non-acylglycerophosphate, surfactants as bilayer-forming substances, e.g. cationic lipids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51Nanocapsules; Nanoparticles
    • A61K9/5107Excipients; Inactive ingredients
    • A61K9/5123Organic compounds, e.g. fats, sugars
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B82NANOTECHNOLOGY
    • B82YSPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y40/00Manufacture or treatment of nanostructures
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B82NANOTECHNOLOGY
    • B82YSPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Dispersion Chemistry (AREA)
  • Biochemistry (AREA)
  • Optics & Photonics (AREA)
  • Physics & Mathematics (AREA)
  • Nanotechnology (AREA)
  • Biomedical Technology (AREA)
  • Biophysics (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Steroid Compounds (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Investigating Or Analysing Biological Materials (AREA)

Abstract

En la presente se proporcionan métodos de alto rendimiento para optimizar y elaborar diversas composiciones de nanopartículas lipídicas (LNP) y sus usos. Por ejemplo, en algunas formas de realización, la presente divulgación proporciona un método de cribado de alto rendimiento para elaborar una composición de LNP que comprende obtener al menos dos soluciones que se pueden mezclar entre sí que comprenden una carga útil y una pluralidad de moléculas capaces de autoensamblarse y mezclar dichas al menos dos soluciones en un conjunto de condiciones controladas, mediante las cuales varían la secuencia de inyección, velocidad, volumen, relación de fase y duración de mezclado. En diversas formas de realización, la presente divulgación permite determinar la eficacia de encapsulación, distribución de tamaño de partícula, purificación, tasa de recuperación de partícula y estabilidad de formulación óptimas. Los métodos divulgados en la presente permiten una optimización eficaz de las condiciones de elaboración para la preparación de agentes terapéuticos a base de LNP. Reivindicación 1: Un método de cribado de alto rendimiento optimizado para elaborar una preparación de nanopartícula lipídica (LNP) que comprende: a. obtener una primera solución que comprende una fase acuosa; b. obtener una segunda solución que comprende una fase orgánica y una pluralidad de moléculas capaces de autoensamblarse, y en donde dichas primera y segunda soluciones se pueden mezclar entre sí; c. disolver al menos una molécula de carga útil en la primera o segunda solución; d. usar un manipulador de líquidos robótico para preparar y distribuir dichas fases con distintas composiciones en una pluralidad de cavidades; e. mezclar dichas primera y segunda soluciones para obtener nanopartículas lipídicas que encapsulan dicha carga útil usando dicho manipulador de líquidos robótico en condiciones adecuadas para la formación de LNP; en donde al menos una de las siguientes condiciones es distinta entre las diferentes cavidades: tipo de molécula de autoensamblaje, relación de composición de dicha molécula de autoensamblaje; relación y/o concentración de dicha molécula de autoensamblaje a dicha carga útil, la selección de fase, tipo de amortiguador y pH, la secuencia de inyección, velocidad de inyección, velocidad de mezclado, volumen, relación de fase, duración de inyección y duración de mezclado; f. medir al menos uno de los siguientes: eficacia de encapsulación, distribución de tamaño de partícula, purificación y tasa de recuperación de partícula y estabilidad de formulación de dichas LNP; g. determinar los parámetros óptimos para elaborar dicha preparación de LNP; y h. elaborar dicha preparación de LNP en función de dichos parámetros óptimos.
ARP210103407A 2020-12-09 2021-12-07 Métodos de alto rendimiento para preparar nanopartículas lipídicas y sus usos AR124267A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US202063123343P 2020-12-09 2020-12-09

Publications (1)

Publication Number Publication Date
AR124267A1 true AR124267A1 (es) 2023-03-01

Family

ID=80218499

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP210103407A AR124267A1 (es) 2020-12-09 2021-12-07 Métodos de alto rendimiento para preparar nanopartículas lipídicas y sus usos

Country Status (12)

Country Link
US (1) US20230330023A1 (es)
EP (1) EP4259104A1 (es)
JP (1) JP2023552815A (es)
KR (1) KR20230118129A (es)
CN (1) CN116669711A (es)
AR (1) AR124267A1 (es)
AU (1) AU2021396518A1 (es)
CA (1) CA3203463A1 (es)
IL (1) IL303456A (es)
MX (1) MX2023006792A (es)
TW (1) TW202237068A (es)
WO (1) WO2022125622A1 (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2022376919A1 (en) * 2021-10-26 2024-03-21 Genentech, Inc. High-throughput methods for preparing lipid nanoparticles and uses thereof
WO2024013149A1 (en) * 2022-07-12 2024-01-18 Sartorius Stedim Biotech Gmbh Lipid nanoparticle production system and method of monitoring and controlling the same
WO2024028492A1 (en) * 2022-08-04 2024-02-08 Sanofi Quantitative assessment of rna encapsulation

Family Cites Families (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4270537A (en) 1979-11-19 1981-06-02 Romaine Richard A Automatic hypodermic syringe
US4596556A (en) 1985-03-25 1986-06-24 Bioject, Inc. Hypodermic injection apparatus
US4886499A (en) 1986-12-18 1989-12-12 Hoffmann-La Roche Inc. Portable injection appliance
GB8704027D0 (en) 1987-02-20 1987-03-25 Owen Mumford Ltd Syringe needle combination
US4790824A (en) 1987-06-19 1988-12-13 Bioject, Inc. Non-invasive hypodermic injection device
US4940460A (en) 1987-06-19 1990-07-10 Bioject, Inc. Patient-fillable and non-invasive hypodermic injection device assembly
US4941880A (en) 1987-06-19 1990-07-17 Bioject, Inc. Pre-filled ampule and non-invasive hypodermic injection device assembly
US5339163A (en) 1988-03-16 1994-08-16 Canon Kabushiki Kaisha Automatic exposure control device using plural image plane detection areas
FR2638359A1 (fr) 1988-11-03 1990-05-04 Tino Dalto Guide de seringue avec reglage de la profondeur de penetration de l'aiguille dans la peau
US5312335A (en) 1989-11-09 1994-05-17 Bioject Inc. Needleless hypodermic injection device
US5064413A (en) 1989-11-09 1991-11-12 Bioject, Inc. Needleless hypodermic injection device
US5190521A (en) 1990-08-22 1993-03-02 Tecnol Medical Products, Inc. Apparatus and method for raising a skin wheal and anesthetizing skin
US5527288A (en) 1990-12-13 1996-06-18 Elan Medical Technologies Limited Intradermal drug delivery device and method for intradermal delivery of drugs
GB9118204D0 (en) 1991-08-23 1991-10-09 Weston Terence E Needle-less injector
SE9102652D0 (sv) 1991-09-13 1991-09-13 Kabi Pharmacia Ab Injection needle arrangement
US5328483A (en) 1992-02-27 1994-07-12 Jacoby Richard M Intradermal injection device with medication and needle guard
US5383851A (en) 1992-07-24 1995-01-24 Bioject Inc. Needleless hypodermic injection device
US5569189A (en) 1992-09-28 1996-10-29 Equidyne Systems, Inc. hypodermic jet injector
US5334144A (en) 1992-10-30 1994-08-02 Becton, Dickinson And Company Single use disposable needleless injector
WO1995024176A1 (en) 1994-03-07 1995-09-14 Bioject, Inc. Ampule filling device
US5466220A (en) 1994-03-08 1995-11-14 Bioject, Inc. Drug vial mixing and transfer device
US5599302A (en) 1995-01-09 1997-02-04 Medi-Ject Corporation Medical injection system and method, gas spring thereof and launching device using gas spring
US5730723A (en) 1995-10-10 1998-03-24 Visionary Medical Products Corporation, Inc. Gas pressured needle-less injection device and method
US5893397A (en) 1996-01-12 1999-04-13 Bioject Inc. Medication vial/syringe liquid-transfer apparatus
GB9607549D0 (en) 1996-04-11 1996-06-12 Weston Medical Ltd Spring-powered dispensing device
US5993412A (en) 1997-05-19 1999-11-30 Bioject, Inc. Injection apparatus
IT1298087B1 (it) 1998-01-08 1999-12-20 Fiderm S R L Dispositivo per il controllo della profondita' di penetrazione di un ago, in particolare applicabile ad una siringa per iniezioni
US20050222064A1 (en) 2002-02-20 2005-10-06 Sirna Therapeutics, Inc. Polycationic compositions for cellular delivery of polynucleotides
US9592198B2 (en) * 2013-10-28 2017-03-14 University Of Maryland, College Park Microfluidic liposome synthesis, purification and active drug loading
WO2016118724A1 (en) 2015-01-21 2016-07-28 Moderna Therapeutics, Inc. Lipid nanoparticle compositions
US20180085474A1 (en) 2015-01-23 2018-03-29 Moderna Therapeutics, Inc. Lipid nanoparticle compositions
ES2913626T3 (es) 2015-12-22 2022-06-03 Modernatx Inc Compuestos y composiciones para la administración intracelular de agentes
WO2017147215A1 (en) * 2016-02-22 2017-08-31 The Methodist Hospital Biomimetic proteolipid vesicle compositions and uses thereof
US20190167811A1 (en) 2016-04-13 2019-06-06 Modernatx, Inc. Lipid compositions and their uses for intratumoral polynucleotide delivery
WO2017223135A1 (en) * 2016-06-24 2017-12-28 Modernatx, Inc. Lipid nanoparticles

Also Published As

Publication number Publication date
AU2021396518A9 (en) 2024-10-10
WO2022125622A1 (en) 2022-06-16
CN116669711A (zh) 2023-08-29
US20230330023A1 (en) 2023-10-19
AU2021396518A1 (en) 2023-07-06
JP2023552815A (ja) 2023-12-19
CA3203463A1 (en) 2022-06-16
EP4259104A1 (en) 2023-10-18
TW202237068A (zh) 2022-10-01
MX2023006792A (es) 2023-06-20
IL303456A (en) 2023-08-01
KR20230118129A (ko) 2023-08-10

Similar Documents

Publication Publication Date Title
AR124267A1 (es) Métodos de alto rendimiento para preparar nanopartículas lipídicas y sus usos
Cai et al. Polarization-sensitive optoionic membranes from chiral plasmonic nanoparticles
Li et al. Recent developments in the construction of metallacycle/metallacage-cored supramolecular polymers via hierarchical self-assembly
Dürr et al. When detergent meets bilayer: birth and coming of age of lipid bicelles
Parsegian et al. [29] Osmotic stress for the direct measurement of intermolecular forces
Blosser et al. cDICE method produces giant lipid vesicles under physiological conditions of charged lipids and ionic solutions
Ivankin et al. Cholesterol mediates membrane curvature during fusion events
CN103196733B (zh) 一种显示镍基高温合金的金相组织所用的侵蚀剂及方法
Khan et al. Real‐Time Imaging of Ammonia Release from Single Live Cells via Liquid Crystal Droplets Immobilized on the Cell Membrane
JP7233632B2 (ja) 磁気相互作用を用いたキラル化合物の分離システムおよび方法
CN106770049A (zh) 基于DNA折纸模板和纳米金棒构建Dolmen结构的方法
Xu et al. A simple and visual approach for enantioselective recognition through supramolecular gels with specific selectivity
CN108031549B (zh) 一种用于多种粒子连续分离的磁分离装置及方法
Xu et al. Surfactant-induced chirality transfer, amplification and inversion in a cucurbit [8] uril–viologen host–guest supramolecular system
Chen et al. Supramolecular Copolymers Under Kinetic, Thermodynamic, or Pathway‐Switching Control
CN102675412B (zh) 一种制备蛋白质晶体的方法
JP2022505763A (ja) イリノテカンリポソーム製剤とその製造及び応用
Hu et al. Microfluidic fabrication of polymersomes enclosing an active Belousov-Zhabotinsky (BZ) reaction: Effect on their stability of solute concentrations in the external media
AR127469A1 (es) Métodos de alto rendimiento para preparar nanopartículas lipídicas y sus usos
CN103128309A (zh) 水溶性生物相容性单分散球形金纳米晶体的合成方法
Lin et al. Controllable 1D, 2D and 3D supramolecular assemblies of Ir (iii) complexes
Wang et al. DNA nanochannels
RU2024113785A (ru) Высокопроизводительные способы получения липидных наночастиц и варианты их применения
Tsuji et al. Protein synthesis with liposome fusion and fission by using the freeze-thaw method
Fuhrhop et al. Synkinetic natural compound chemistry